For decades, animal models have been the default in biomedical research, but their limitations have become impossible to ignore. From mice to monkeys, these models often fail to replicate the complex biology of human diseases, leading to treatments that work in the lab but fall short in real-world patients.

Human biospecimens, like blood, tissue, DNA, and other biological samples, offer a more accurate, direct window into human health. They capture the genetic, epigenetic, and environmental factors that animal models simply can’t mimic. This is especially crucial in areas like oncology, neurology, and rare diseases, where precision is everything and variability can be the difference between success and failure.

Driven by the need for more accurate, ethical, and scalable research tools, AminoChain is helping drive the global shift toward human-first science. By making high-quality, diverse, and ethically sourced samples more accessible than ever, we’re helping researchers cut through the noise, reduce translational failure, and accelerate the path from discovery to therapy.

Animal models helped get us this far. But to go further, to create medicine that truly reflects the people it serves, we need to go human-first.

Learn more about how we are contributing to human-first science at https://t.co/umgcZo104i